New agreement between Novartis and the NHS enables broad and rapid access to cholestrol lowering medicine ‘Inclisiran’. In December 2019, an in-principle agreement was made…
View More New approaches to Lipid management
Tag: atherosclerotic cardiovascular disease (ASCVD)
